MGX 8-K 2026-01-12

Metagenomi, Inc. (MGX) 8-K dated 2026-01-12 — accession 0001193125-26-009928. This URL is the filing, not the MGX hub.

Metagenomi, Inc. (MGX) is a biotechnology company listed on NASDAQ.

Metagenomi, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009928.

Cached items: 5.03, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.

Not investment advice. The MGX SEC hub lists recent forms. The stock page is the research view.